检索

Evaluation of the efficacy of introduction of a new medical technology fortreatment of chronic dermatoses based on the application of activated zincpyrithione

Kubanov A., Petrovsky F.

(Rus)

Results of the study of Cinocap cream clinical efficacy andsafety

Danilova A., Kosorukova I., Danilova A., Kosorukova I.

(Rus)

Possibility to use Ademetionine for the treatment of psoriaticpatients with a pathology of the hepatobiliary system

Matusevich S., Medvedeva I., Matusevich S., Medvedeva I.

(Rus)

卷 86, 编号 2 (2010)

Search for potential biomarkers of inveterate dermatoses by means of proteomic analysis

BRATSEVA Y., MOSHKOVSKY S., ZNAMENSKAYA L., KUBANOVA A., KUBANOV A.

(Rus)

卷 88, 编号 4 (2012)

Capabilities of the basic treatment preparations in the combined treatment of psoriasis

Hobeysh M., Monakhov K., Sokolovsky E.

(Rus)

卷 88, 编号 4 (2012)

Search for new molecular targets for anticytokine therapy of patients, suffering from the immune dependent skin disease — psoriasis

KUBANOV A., FRIGO N., ROTANOV S., HAYRULLIN R., ZNAMENSKAYA L., SVISHTCHENKO S.

(Rus)

Experience of treatment of psoriatic patients with monochromic ultraviolet light from excimer lamps in a combination with external drugs

NEMCHANINOVA O.

(Rus)

卷 89, 编号 1 (2013)

Melanocytic nevi in psoriasis patients: results of a study with the use of dermatoscopy

Sergeyeva I., Krinitsyna Y., Onipchenko V., Makarova N.

(Rus)

卷 95, 编号 5 (2019)

Distribution of melanocytes in the skin of psoriasis patients

Zhukov A., Khairutdinov V., Belousova I., Samtsov A.

(Rus)

卷 94, 编号 4 (2018)

Features of treatment of patients with psoriasis with metabolic syndrome

Khairutdinov V., Samtsov A.

(Rus)

卷 93, 编号 5 (2017)

Signaling Рathway Blockers: Action Mechanism, Efficacy, Safety of Therapy for Patients with Psoriasis and Psoriatic Arthritis

Bakulev A.

(Rus)

卷 93, 编号 1 (2017)

Methotrexate: Revisited efficiency and safety of drug administration in psoriasis patients

Bakulev A.

(Rus)

卷 92, 编号 4 (2016)

Anti-cytokine therapy of a patient suffering from psoriatic arthritis

Onipchenko V., Sergeeva I., Krinitsyina Y., Kondrashova A., Pahomova V., Hismatulina N.

(Rus)

卷 91, 编号 3 (2015)

Dynamics of expression rates of growth factor proteins in psoriatic patients receiving a phototherapy

Chikin V., Zhilova M., Smolyannikova V., Nefedova M.

(Rus)

卷 100, 编号 4 (2024)

Dermatovenereology in the Russian Federation: results of 2023

Kubanov A., Bogdanova E.

(Rus)

卷 99, 编号 5 (2023)

Efficacy and safety of netakimab therapy in patients with moderate to severe psoriasis in real clinical practice

Bakulev A., Pritulo O., Kuntsevich Z., Khotko A., Yunovidova A., Gorognichev P., Ziganshin O., Rudneva N., Bildyuk E., Repina T., Dudko V., Maksimova M.

(Rus)

卷 98, 编号 5 (2022)

The role of cells of the innate immune system in psoriasis

Sorokina E., Bisheva I.

(Rus)

卷 97, 编号 2 (2021)

Perspective trends of topical therapy of patients with psoriasis

Zhukov A., Khairutdinov V., Samtsov A.

(Rus)

卷 96, 编号 4 (2020)

Targeted therapy of psoriasis: inhibition of the IL-23 signaling pathway — evidence from clinical studies and real practice

Hotko A., Pomazanova M., Kruglova L.

(Rus)

Problems with differential diagnostics of seborrheic dermatitis and plaque psoriasis by the exampleof a particular case study

Samtsov A., SAMTSOV A.

(Rus)

卷 87, 编号 4 (2011)

Pro-inflammatory IL-1 and TNF alpha cytokines in affected skin foci in psoriatic patients

Katunina O., Rezaykina A., Katunina O., Rezaikina A.

(Rus)

卷 86, 编号 2 (2010)

Efficacy and safety of treatment of patients suffering from severe forms of psoriasis

BAKULEV A., KRAVCHENYA S., SLESARENKO N., SHABOGINA A.

(Rus)

Current clinical features in the course of psoriasis and psoriasiform states in children

MURASHKIN N., KUBANOVA A.

(Rus)

卷 86, 编号 4 (2010)

Assessment of the cytokine profile in psoriasis patients against the background of an immune-modulating therapy

OKHLOPKOV V., MEDVEDCHIKOV E., DOLGIKH T., PRAVDINA O., GORODILOV R., ZARAYEVA I.

(Rus)

Studying of relationship of Histocompatibility antigens and N-acetylation phenotype in patients of Uzbek populations with psoriasis

IBRAGIMOV S., MANSUROVA G., MAMATKULOV U., MAKHSUDOV M.

(Rus)

Role of CD11c-positive dendrite cells in the psoriasis pathogenesis

HAIRUTDINOV V.

(Rus)

卷 88, 编号 2 (2012)

Pharmacoeconomic aspects of treatment of psoriasis with biological drugs

Rudakova A., Kubanov A.

(Rus)

卷 96, 编号 1 (2020)

Profiles of patients with psoriasis for appointment gene-engineering biological therapy — clinical justification

Zhukov A., Khotko A., Khairutdinov V., Samtsov A.

(Rus)

卷 94, 编号 6 (2018)

Experience in the treatment of psoriasis patients using Apremilast, a selective signalling pathway inhibitor

Kungurov N., Zilberberg N., Kokhan M., Keniksfest J., Grishaeva E.

(Rus)

卷 94, 编号 6 (2018)

Psoriatic onychodystrophy: clinical manifestations (part 1)

Platonova A., Zhukov A., Khairutdinov V., Samtsov A.

(Rus)

卷 93, 编号 4 (2017)

SYSTEM THERAPY OF PSORIASIS IN CHILDREN (PART I)

Namazova-Baranova L., Murashkin N., Ambarchyan E., Materikin A.

(Rus)

卷 92, 编号 5 (2016)

Selective intracellular inhibition of signalling pathways - new direction in systematic treatment of psoriasis patients

Bakulev A.

(Rus)

卷 92, 编号 3 (2016)

A case of psoriasiform syphilid (from clinical practice)

Koshkin S., Chermnykh T., Kovrova O., Ryabov N.

(Rus)

卷 91, 编号 1 (2015)

Endothelial dysfunction and its treatment in psoriasis patients

Shtoda Y., Slesarenko N., Bakulev A., Utz S., Platonova A.

(Rus)

卷 99, 编号 5 (2023)

Search for predictors of psoriatic arthritis in patients with psoriasis

Artamonova O., Karamova A., Kubanov A., Verbenko D., Kozlova I.

(Rus)

卷 98, 编号 6 (2022)

Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis

Bogdanova E.

(Rus)

卷 97, 编号 2 (2021)

Clinical evidence of therapy for genital psoriasis by biologic agents

Sokolovskiy E., Kokhan M.

(Rus)

卷 96, 编号 2 (2020)

Comparative study of anti-inflammatory activity of zinc pyrition on a psoriasis laboratory model

Zhukov A., Khairutdinov V., Samtsov A.

(Rus)

Changes in the hormonal status of patients with focal psoriasis vulgaris

Vasil'ev A., Zaslavskiy D., Trashkov A., Kravtsova A., Kazikhanova S., Khayrutdinov V., Khvedelidze M., VASILIYEV A., ZASLAVSKY D., TRASHKOV A., KRAVTSOVA A., KAZIKHANOVA S., KHAIRUTDINOV V., KHVEDELIDZE M.

(Rus)

卷 87, 编号 3 (2011)

Affected skin examination in psoriatic patients in the courseof Infliximab therapy (a morphologic analysis)

Katunina O., Znamenskaya L., Matushevskaya Y., Katunina O., Znamenskaya L., Matushevskaya Y.

(Rus)

Role of recognizing receptors in the initiation of immune inflammation in theskin of psoriasis patients

Katunina O., Rezaikina A., Kolykhalova O.

(Rus)

Functions of Toll-like receptors as an inborn immunity component and their participation in the pathogenesis of dermatoses of different etiologies

KATUNINA O.

(Rus)

Intestinal helminth and protozoan infections in patients withchronic dermatoses

Gerasimova N., Kokhan M., Belykh O., Keniksfest Y., Gerasimova N., Kokhan M., Belykh O., Keniksfest Y.

(Rus)

卷 86, 编号 3 (2010)

Currentaspects of psoriasis phototherapy

Zhilova M., Butareva M., Volnukhin V., Zhilova M., Butareva M., Volnukhin V.

(Rus)

TLR - possible molecular target for biologic psoriasis therapy

Katunina O., Rezaykina A.

(Rus)

卷 89, 编号 4 (2013)

Rational external therapy of scalp psoriasis

Perlamutrov Y., Olkhovskaya K.

(Rus)

卷 95, 编号 6 (2019)

Guselkumab in the treatment of patients with plaque psoriasis of moderate and severe severity: Efficacy and safety of interleukin-23 blockade

Chikin V.

(Rus)

卷 95, 编号 4 (2019)

Studying of the interleukin-36γ expression level in the skin of patients with plaque psoriasis

Pashkin A., Zhukov A., Khairutdinov V., Belousova I., Samtsov A., Garabagiou A.

(Rus)

卷 93, 编号 6 (2017)

Systemic Psoriasis Treatment at an Early Age (Part II): Issues of Biological Therapy

Namazova-Baranova L., Murashkin N., Ambarchian E., Materikin A.

(Rus)

卷 93, 编号 5 (2017)

Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis

Samtsov A., Khairutdinov V., Bakulev A., Kubanov A., Karamova A., Artem’eva A., Korotaeva T.

(Rus)

卷 92, 编号 5 (2016)

Chronic inflammation, insulin resistance, psoriasis - which have in common?

Rasin M.

(Rus)

卷 92, 编号 1 (2016)

Influence of natural factors Saki lake combined with “Berlition® 600” (Thioctic acidi) on immunoregulatory processes taking into account morphological changes of skin in patients with plaque psoriasis

Kuznetsova M., Pritulo O., Prokhorov D.

(Rus)

卷 91, 编号 1 (2015)

Personalization of an anti-cytokine therapy of psoriatic patients

Kubanov A., Svishchenko S.

(Rus)

卷 100, 编号 3 (2024)

Features of psoriasis treatment with infection COVID-19

Tashkenbaeva U., Aliev A., Usmanaliev S.

(Rus)

卷 99, 编号 4 (2023)

Predictive model and classification for psoriatic arthritis risk assessment for Russian patients with psoriasis (on registry data)

Bogdanova E.

(Rus)

卷 98, 编号 4 (2022)

The age at first cutaneous manifestation of psoriasis as a prognostic factor in the timing of psoriatic arthritis diagnosis

Bogdanova E.

(Rus)

卷 98, 编号 1 (2022)

Epidemiology of psoriasis in the Russian Federation according to the patient registry

Kubanov A., Bogdanova E.

(Rus)

卷 96, 编号 2 (2020)

The Actual Challenges of Biologics Treatment in Patients with Psoriasis

Bakulev A.

(Rus)

The role of T-regulatory cells in the pathogenesis of psoriasis

Khayrutdinov V., Mikhaylichenko A., Mukhina M., Samtsov A., Imyanitov E., Ivanov A., KHAIRUTDINOV V., MICHAILICHENCO A., MUKHINA M., SAMTSOV A., IMYANITOV E., IVANOV A.

(Rus)

卷 87, 编号 4 (2011)

Genetic profile of psoriasis patients

Khayrutdinov V., Khairutdinov V.

(Rus)

Personalized approach to the selection of therapy for patients with psoriasisbased on the results of molecular and genetic tests

Znamenskaya L., Frigo N., Rotanov S., Volkov I., Volnukhin V., Zhilova M.

(Rus)

Combination treatment of psoriasis patients with kartalinointment and ehf therapy

Dmitruk V., Dmitruk V.

(Rus)

Inhibitors of tumor necrosis factor-alpha for treatment ofpsoriatic patients

Znamenskaya L., Znamenskaya L.

(Rus)

Molecular Markers In Forecasting The Clinical Efficacy Of Infliximab In Psoriasis Patients

KUBANOVA A., LESNAYA I., FRIGO N., KAGANOVA N., ZNAMENSKAYA L., KUBANOV A.

(Rus)

Current topical therapy of psoriatic patients suffering from scalp lesions

FILIMONKOVA N., TOPYCHKANOVA Y.

(Rus)

卷 89, 编号 5 (2013)

Results of a study of genetic factors predisposing to the development of psoriasis among the population of the Russian Federation

MINEYEVA A., KOZHUSHNAYA O., ZNAMENSKAYA L., CHIKIN V., FRIGO N.

(Rus)

卷 95, 编号 2 (2019)

Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis

Olisova O., Svistunova D., Chernyavskaya L., Anpilogova E.

(Rus)

卷 95, 编号 3 (2019)

Influence of focal infection on the immune status of psoriasis patients

Patrushev A., Samtsov A., Nikitin V., Sukharev A., Ivanov A., Gumilevskaya O., Sukhina I.

(Rus)

卷 94, 编号 3 (2018)

Psoriasis: clinical and epidemiological features and therapy issues

Bakulev A., Fitileva T., Novodezerkina E., Gilloteau I., Tian Н., Howe T., Pietri G.

(Rus)

卷 93, 编号 4 (2017)

ASSOCIATED PATHOLOGY: CLINICAL ОBSERVATION

Tlish M., Popovskayа E., Sycheva N., Sorokina N., Psavok F.

(Rus)

卷 92, 编号 5 (2016)

Strategy “treat to target” for patients with psoriasis. Relevant issues to biological therapy persistence

Bakulev A.

(Rus)

卷 91, 编号 5 (2015)

ISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS IN PATIENT SUFFERING FROM PLAQUE PSORIASIS: A CASE REPORT

Znamenskaya L., Chikin V., Kappusheva I., Kondrasheva V.

(Rus)

卷 90, 编号 6 (2014)

Inflammation and itching in patients suffering from atopic dermatitis and psoriasis. Assessment of the expression of neurotrophins аnd neuropeptides

Smolyannikova V., Kubanova A., Chikin V., Karamova A.

(Rus)

卷 100, 编号 3 (2024)

Comparative evaluation of the effectiveness of balneotherapy and balneotherapy in combination with intravenous laser irradiation of blood at the period of spa treatment of patients with psoriasis

Sadovskaya E., Gorlova N., Sherengovskaya Y., Pritulo O., Prokhorov D., Ravlyuk D., Gumenyuk L.

(Rus)

卷 99, 编号 4 (2023)

Resources and performance rates of medical organizations providing medical care in the field of dermatovenereology in the Russian Federation in 2016–2022

Kubanov A., Bogdanova E.

(Rus)

卷 98, 编号 4 (2022)

Efficacy and safety of treatment of moderate and severe psoriasis with the interleukin 23 inhibitor risankizumab

Bakulev A., Kruglova L.

(Rus)

卷 97, 编号 3 (2021)

The new external drug for the treatment of psoriasis based on inhibition of serine proteases

Zhukov A., Zharun E., Khairutdinov V., Samtsov A., Krasavin M., Garabagiou A.

(Rus)

卷 96, 编号 4 (2020)

Assessment of CLA+T-cell subpopulations in the blood of patients with chronic dermatoses

Patrushev A., Samtsov A., Nikitin V., Soukharev A., Gumilevskaya O., Sukhina I.

(Rus)

Immunohistochemical analysis of molecular cell structures of genetic and adaptive immunityin patients suffering from psoriasis in the course of biological therapy

Katunina O., KATUNINA O.

(Rus)

Clobetasol propionate (Dermovate) gives new opportunities in the treatment ofdermatoses

Khlebnikova A.

(Rus)

卷 86, 编号 4 (2010)

Assessment of the clinical efficacy of the administration of Phosphogliv in complex treatment of psoriasis patients

Orlov Y., Konnov P., Kotelnikova Y.

(Rus)

卷 86, 编号 4 (2010)

Clinical, molecular and genetic studies of efficacy and safety of using UV irradiation for psoriasis patients

Zhilova M., Kubanov A., Lesnaya I., Frigo N., Volkov I., Znamenskaya L., Volnukhin V.

(Rus)

Administering hepatoprotectors for psoriasis: a comparative clinical, laboratory and ultrasonic assessment of its efficacy

BAKULEV A., KRAVCHENYA S.

(Rus)

卷 88, 编号 4 (2012)

Biological therapy of patients with severe psoriasis

NV KUNGUROV M., KENICKSFEST Y., Keniksfest Y.

(Rus)

Study of the genetic factors predisposing to the development of psoriasis

MINEEVA A., KOZHUSHNAYA O., VOLNUKHIN V., FRIGO N., ZNAMENSKAYA L., KUBANOV A., MELEKHINA L.

(Rus)

Pathogenic value of neuropeptides and growth factor proteins for the development of inflammation and itching in patients with prevalent dermatoses

CHIKIN V., ROTANOV S., KHAIRULLIN R., ZNAMENSKAYA L., VAKHITOVA I., INOYATOVA L.

(Rus)

卷 95, 编号 3 (2019)

Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext

Bakulev A., Samtsov A., Kubanov A., Khairutdinov V., Kokhan M., Artemyeva A., Derbin S., Chernyaeva E., Ivanov R.

(Rus)

卷 95, 编号 2 (2019)

Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis

Kubanov A., Bakulev A., Samtsov A., Khairutdinov V., Sokolovskiy E., Kokhan M., Artemyeva A., Chernyaeva E., Ivanov R.

(Rus)

卷 94, 编号 5 (2018)

Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for the treatment of patients suffering from psoriasis

Bakulev A.

(Rus)

卷 93, 编号 3 (2017)

ACRODERMATITIS CONTINUA SUPPURATIVA HALLOPEAU IN COMBINATION WITH LOCALIZED PSORIASIS VULGARIS

Sokolovskiy E., Mikheev G.,  Gordeeva A.

(Rus)

卷 92, 编号 3 (2016)

Using clobetasol propionate in the form of a shampoo for the treatment of patients suffering from psoriasis localized in the scalp area

Bakulev A., Kravchenya S., Igonina I., Utz S.

(Rus)

卷 91, 编号 6 (2015)

A case of generalized pustular psoriasis

Oklopkov V., Pravdina O., Chermoschentsev A., Repina T., Poleshuk E., Gudoshnik V., Gorodilov R.

(Rus)

卷 90, 编号 6 (2014)

Prevalence of genetic risk factors of psoriasis among the population of the Russian Federation

Kubanov A., Kubanova A., Karamova A., Mineyeva A.

(Rus)

卷 100, 编号 2 (2024)

Experience of using genetic engineering biological therapy in a patient with psoriasis and chronic renal failure under hemodialysis

Kulakova E., Rybalkin S.

(Rus)

卷 99, 编号 2 (2023)

A prospective open-label study of the antifungal activity of external forms of activated zinc pyrithione in the treatment of Malassezia-associated skin diseases

Samtsov A., Patrushev A., Chepushtanova K., Bogdanova T., Alekssev A., Bogomolova T., Vasilyeva N.

(Rus)

卷 98, 编号 2 (2022)

Efficacy and safety profile of 2-year netakimab treatment in patients with moderate-to-severe plaque psoriasis in terms of the randomized double-blind placebo-controlled BCD-085-7/PLANETA clinical trial

Bakulev A., Samtsov A., Sokolovskiy E., Kokhan M., Khobeish M., Khairutdinov V., Karamova A., Olisova O., Ignatiev D., Nikiforova A., Artemeva A., Zinkina-Orikhan A.

(Rus)

卷 97, 编号 6 (2021)

Disorders of the skin microbiome in atopic dermatitis and psoriasis

Nikolaeva M., Monakhov K., Sokolovskiy E.

(Rus)

卷 96, 编号 3 (2020)

Systemic treatment of psoriasis: from methotrexate to biologics

Olisova O., Anpilogova E.

(Rus)

卷 87, 编号 6 (2011)

Association of polymorphism of IL12B gene and predisposition to psoriasis among the populationof the Northwestern region of Russia

Khayrutdinov V., Mikhaylichenko A., Piskunova A., Samtsov A., Ivanov A., Imyanitov E., KHAIRUTDINOV V., MIKHAILICHENKO A., PISKUNOVA A., SAMTSOV A., IVANOV A., IMYANITOV Y.

(Rus)

卷 87, 编号 3 (2011)

Proteome technologies in studying the pathogenesisof psoriasis

Znamenskaya L., Znamenskaya L.

(Rus)

卷 86, 编号 2 (2010)

Possibilities of enhancement of the efficiency of complex psoriasis treatment

VLADIMIROVA I., MONAKHOV K.

(Rus)

卷 87, 编号 1 (2011)

The genetic factors in aetiology and pathogenesis of psoriasis

Kungurov N., Filimonkova N., Golubtsov V., Korkhmazova S.

(Rus)

卷 88, 编号 6 (2012)

A study of the efficacy of using the Kartalin ointment in a complex with exogenous melatonin for psoriasis

DMITRUK V., MARTYNOVA V., KAMYSHNIKOVA O., DMITRUK S.

(Rus)

Use of Skin-Cap (activated zinc pyrithione) in the therapy of chronic dermatoses

(Rus)

卷 88, 编号 1 (2012)

Current approaches to the external therapy of psoriasis

KHLEBNIKOVA A.

(Rus)

卷 89, 编号 2 (2013)

Scalp psoriasis: new potential of the topical therapy

Bakulev A., Kravchenya S.

(Rus)

卷 95, 编号 6 (2019)

Precision therapy for psoriasis patients

Zhukov A., Khairutdinov V., Samtsov A.

(Rus)

卷 94, 编号 5 (2018)

Effectiveness of resuming ustekinumab therapy in psoriasis patients with metabolic disorders. Clinical experience

Rychkova I., Prytulo O.

(Rus)

卷 94, 编号 3 (2018)

Prevalence of chronic infection foci in patients with dermatoses

Patrushev A., Samtsov A., Ivanov A., Sukharev A., Asfendiarov D.

(Rus)

卷 92, 编号 6 (2016)

Efficacy of the combined therapy with etanercept and methotrexat at the female patient with generalized pustular psoriasis and arthritis psoriasis after the therapeutic failure of two the TNF-α receptor inhibitors. Case study

Vustina V., Grigoriadi N., Korotayeva T.

(Rus)

卷 92, 编号 4 (2016)

Immune pathogenesis of psoriasis

Khairutdinov V., Belousova I., Samtsov A.

(Rus)

卷 90, 编号 4 (2014)

Particular features of lipid metabolism in psoriasis patients with concomitant metabolic syndrome

Pashinyan A., Dontsova Y.

(Rus)

卷 101, 编号 1 (2025)

Blood cytokines as potential predictors of therapy effectiveness in patients with moderate to severe psoriasis treated with the IL-12/IL-23 inhibitor ustekinumab

Karamova A., Vorontsova A., Nikonorov A., Nikonorova E., Kubanov А.

(Rus)

卷 100, 编号 2 (2024)

The role of exosomes in the diagnostics and treatment of immune mediated skin disoders, wounds and alopecia

Palkina N., Zenaishvili R., Ruksha T.

(Rus)

卷 99, 编号 1 (2023)

Periods till psoriatic arthritis onset and diagnosis in Russian patients with moderate to severe psoriasis (according to psoriasis patient registry)

Kubanov A., Bogdanova E.

(Rus)

卷 97, 编号 5 (2021)

Experience of using ustekinumab in the treatment of a patient with HIV-associated psoriasis and anogenital warts

Babkova M., Arshinsky M., Frolova Z., Chudina O., Mitrofanova J., Batalova S.

(Rus)

卷 97, 编号 5 (2021)

Revisiting the question of psoriasis classification

Karamova A., Olisova O., Bakulev A., Kokhan M., Khairutdinov V., Sokolovskiy E., Khobeych M.

(Rus)

卷 96, 编号 2 (2020)

Recommendations Russian Society of Dermatovenerologists and Cosmetologists for systemic treatment of psoriasis during the pandemic COVID-19

Kubanov A., Bakulev A., Kokhan M., Olisova O., Samtsov A., Sokolovskiy E., Khairutdinov V., Khobeish M.

(Rus)

Markers of efficacy of Infliximab in psoriasis patients

Kubanova A., Znamenskaya L., Frigo N., Volkov I., Rotanov S., Rezaykina A., KUBANOVA A., ZNAMENSKAYA L., FRIGO N., VOLKOV I., ROTANOV S., REZAIKINA A.

(Rus)

卷 87, 编号 1 (2011)

The experience of treatment for palmar and plantar psoriasis

Togoeva L., Minnibaeva M., Lukiyanova E., Korsunskaya I.

(Rus)

A case study: combination of pemphigus foliaceus and psoriasis. Problems of diagnostics

NADGERIYEVA O., ZNAMENSKAYA L., AVDIYENKO I., KATUNINA O., MURUZOVA I.

(Rus)

Mechanism of the biological effect of the tumor necrosis factor-аlpha at psoriasis

ZNAMENSKAYA L., YEGOROVA Y., ZITNER S.

(Rus)

On the efficiency and safety of application of the short course of clobetasol propionate at patients, suffering from psoriasis in the progression phase

BAKULEV A., KRAVHCHENYA S.

(Rus)

Immune mechanisms of psoriasis. New strategies of biotherapy

KUBANOVA A., KUBANOV A., NIKOLAS J., PUIG L., PRINCE J., KATUNINA O., ZNAMENSKAYA L.

(Rus)

Study of the genetic factors predisposing to the development of psoriasis

LVOV A., KATUNINA O., ZNAMENSKAYA L., MICHENKO A., EGOROVA Y., INOYATOVA L., HAIRULLIN R., VOLKOV I.

(Rus)